What is the cause of Dienogest-resistance in patients with endometrioma?

 What is the cause of Dienogest-resistance in patients with endometrioma? By Selma Oransay

Endometriosis may cause infertility in women, leading to adhesions in the pelvis, besides affecting the ovaries. Clinicians concern about the child-bearing desire of their patients when treating them surgically or with hormonal therapy. Dienogest (DNG) is a kind of progestin,…

Key Points Lay Summary

Hormone Therapy Before Endometriosis Surgery

Hormone Therapy Before Endometriosis Surgery By Yu Yu

Hormonal therapy can be effective for endometriosis, although laparoscopic surgery is required for the frequent drug-resistant symptoms. Laparoscopic surgery can markedly improve endometriosis-associated pain. The administration of GnRH agonist prior to endometriosis laparoscopic surgery may be beneficial to improve surgical…

Key Points Lay Summary

Diagnosis and treatment algorithm for endometriosis

Diagnosis and treatment algorithm for endometriosis By Selma Oransay

Endometriosis is a chronic and progressive disease that affects 25-30% of women between 25-35years, clinicians commonly experience during their gynecologic practice. However, the diagnosis is still late or sometimes incorrect, and this creates severe health problems and worse outcomes. A…

Key Points Lay Summary

Long-term Use of Dienogest can Prevent Recurrence of Endometriomas

Long-term Use of Dienogest can Prevent Recurrence of Endometriomas By Kasthuri Nair

Chandra et al. recently published a paper titled “Clinical experience of the long-term use of dienogest after surgery for ovarian endometriomas” in Obstetrics and Gynecology Science. The publication explored the benefits and repercussions associated with long-term use of dienogest, a…

Key Points Lay Summary

Dienogest Use Over A Prolonged Period of Time

Dienogest Use Over A Prolonged Period of Time By Kasthuri Nair

There are not a lot of treatments on the market for endometriosis; however, Dienogest (DNG), a progestin that has high selective progesterone activity along with low androgenic activity, has been found to reduce endometriosis-associated pain. Lee et al. recently published…

Key Points Lay Summary

Short-term effects of dienogest on ovarian endometriomas

Short-term effects of dienogest on ovarian endometriomas By Murat Osman

First-line treatment of symptomatic, uncomplicated ovarian endometriosis is the use of progestins with or without estrogens such as Dienogest (DNG). These drugs are used to inhibit ovulation and thus reduce the estrogenic environment in which endometriosis relies upon for survival.…

Key Points Lay Summary

A New Treatment Time-Table for Controlling Endometriosis-Associated Pelvic Pain

A New Treatment Time-Table for Controlling Endometriosis-Associated Pelvic Pain By Kasthuri Nair

It is no secret that Endometriosis is an extremely painful disease. Unfortunately, science has yet to determine a treatment that can effectively treat the disease or the associated pain. In their paper titled “Ethinylestradiol 20 mg/drospirenone 3 mg in a…

Key Points Lay Summary

Dienogest for Endometriosis

Dienogest for Endometriosis By Kasthuri Nair

Laganà et al. recently published an article in Expert Opinion on Drug Metabolism & Toxicology titled “Clinical dynamics of Dienogest for the treatment of endometriosis: from bench to bedside.” This article explored the benefits of using Dienogest, a progestin, to…

Key Points Lay Summary